These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 33577782)
21. Advance in herpes simplex viruses for cancer therapy. Liu S; Dai M; You L; Zhao Y Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184 [TBL] [Abstract][Full Text] [Related]
22. Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy. Mahoney DJ; Stojdl DF Future Oncol; 2012 Mar; 8(3):219-21. PubMed ID: 22409457 [No Abstract] [Full Text] [Related]
23. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review). Wang X; Zhong L; Zhao Y Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760203 [TBL] [Abstract][Full Text] [Related]
24. Oncolytic viruses: what to expect from their use in cancer treatment. Terrível M; Gromicho C; Matos AM Microbiol Immunol; 2020 Jul; 64(7):477-492. PubMed ID: 31663631 [TBL] [Abstract][Full Text] [Related]
25. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses. Howard F; Muthana M Nanomedicine (Lond); 2020 Jan; 15(1):93-110. PubMed ID: 31868115 [TBL] [Abstract][Full Text] [Related]
26. Biological therapy with oncolytic herpesvirus. Benencia F; Coukos G Adv Exp Med Biol; 2008; 622():221-33. PubMed ID: 18546631 [No Abstract] [Full Text] [Related]
34. Viral cancer therapies: are they ready for combination with other immunotherapies? Boisgerault N; Grégoire M; Fonteneau JF Future Oncol; 2017 Aug; 13(18):1569-1571. PubMed ID: 28776392 [No Abstract] [Full Text] [Related]
35. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy. Lal G; Rajala MS Cancer Gene Ther; 2018 Oct; 25(9-10):216-226. PubMed ID: 29735993 [TBL] [Abstract][Full Text] [Related]
36. Editorial: Oncolytic Virus and Gene Thearapy Application: Update 2018. Abei M Curr Cancer Drug Targets; 2018; 18(2):108. PubMed ID: 29457568 [No Abstract] [Full Text] [Related]
37. Panorama from the oncolytic virotherapy summit. Pol JG; Marguerie M; Arulanandam R; Bell JC; Lichty BD Mol Ther; 2013 Oct; 21(10):1814-8. PubMed ID: 24081122 [No Abstract] [Full Text] [Related]
38. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533 [TBL] [Abstract][Full Text] [Related]